Navigation Links
Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
Date:10/23/2007

of EpCAM in cancer stem cell regulation.

"All of these new findings correlate well together and highlight the prospects of EpCAM-directed immunotherapies," commented Carsten Reinhardt, M.D., Chief Medical Officer of Micromet. "While the findings from our collaborators in Munich may finally explain the well-known negative prognostic potential of EpCAM, the clinical data on adecatumumabs potential inhibitory effect on new metastases provide a clear rationale for moving forward into early-stage cancer settings where the goal is prevention of disease re- occurrence rather than palliative shrinkage of large tumor bulk."

All of the above cited abstracts can be viewed on the AACR website at http://www.aacr.org.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are in clinical development. MT103 (MEDI-538), the first antibody developed using the BiTE(R) technology platform to be clinically validated in Micromet's product pipeline, is being evaluated in a phase 1 clinical trial for the treatment of patients with non- Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, a subsidiary of AstraZeneca plc. The second clinical stage antibody is adecatumumab (MT201), a human monoclonal antibody targeting EpCAM expressing tumors. Adecatumumab is being developed by Micromet in collaboration with Merck Serono, a division of Merck KGaA in Darmstadt, Germany, in a phase 1b clinical trial evaluating MT201 in combination with docetaxel for the treatment of patients with metastatic breast cancer. The third clinical
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Wisconsin Assembly passes capital investment bill, revised CAPCO program not presented
2. Olympics of biotechnology has international flavor
3. Traffic data firm navigates international business
4. Catalyst International profit exceeds expectations
5. Lack of broadband hamstrings international videoconferencing
6. 30 days to success: Three simple steps to create your own international startup
7. TEKLYNX International announces new RFID software
8. Ruling enforces international trademark electronic filing requirements
9. Eleftheriou to lead Catalyst International
10. Internet trademark war goes international
11. International eyes drawn to Madisons games research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... phylum so full of mean little creatures, the yellow-colored Ormia ... -- at least to crickets. Native to the southeastern U.S. ... sort of parasite. It swoops onto the back of a ... its wicked brood to invade, kill and consume the cricket ... possible without the fly,s ability to find a cricket -- ...
(Date:7/22/2014)... engineering at the University of Texas at Dallas, has ... Texas section of the American Society of Mechanical Engineers ... 158 countries who develop engineering standards and training. They ... the world. , ASME recognized Baughn earlier this year ... Baughn retired as an engineering fellow in 2012 after ...
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and ... and other markets, announced today that it has closed ... private investors led by Novit L.P., an investment arm ... involved the signing of a Securities Purchase Agreement under ... at a price per share of $1.00, resulting in ...
(Date:7/22/2014)... 22, 2014 The DNA Spectrum ... concise visual representation of history, migration, and culture. ... regaled by family history stories stemming from Europe. His ... "old country." Pictures and 8mm home movies painted an ... the family, and Steve ordered a test from DNA ...
Breaking Biology Technology:Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4UT Dallas professor receives Engineer of the Year award 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4
... F. DeMeo, M.D., M.B.A., president and chief executive officer ... Demron-M radiation-blocking medical garments at the Radiological Society of ... The event takes place 10 a.m. to 5 p.m. ... Center, 2301 S. Lake Shore Dr., Chicago. North Building, ...
... 26 Micromet, Inc. (Nasdaq: MITI ), a ... of cancer, inflammation and autoimmune diseases, today announced that ... NBI ), effective November 24, 2008. , ... Index was launched in 1993 and includes securities of ...
... TriCipher, the experts in,strong authentication, today announced that ... compliant with the SAFE-BioPharma(TM),digital identity and signature standard. ... 1.1 is an online digital signature workflow solution ... to PDF documents,using Adobe Reader. The ability to ...
Cached Biology Technology: New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric 2Micromet Added to NASDAQ Biotechnology Index 2Micromet Added to NASDAQ Biotechnology Index 3Micromet Added to NASDAQ Biotechnology Index 4MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM) 2MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM) 3
(Date:7/22/2014)... New Orleans, LA -- Nancy Buccola, MSN, APRN, ... LSU Health Sciences Center New Orleans School of ... new locations of genetic material associated with schizophrenia ... immune system and schizophrenia. The study, Biological insights ... July 22, 2014 in Nature , available ...
(Date:7/22/2014)... child,s lunch box and you,re likely to find that the ... are the findings of a study conducted by researchers at ... University and in the Department of Public Health and Community ... are published online ahead of print in the Journal ... Led by senior author Jeanne Goldberg, Ph.D., R.D., a professor ...
(Date:7/22/2014)... of immune cell widely believed to exacerbate chronic ... multiple sclerosis (MS), can actually protect the brain ... the progression of neurodegenerative diseases, according to Cleveland ... Nature Communications . , The research team, ... Department of Neurosciences at Cleveland Clinic,s Lerner Research ...
Breaking Biology News(10 mins):LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2Room for improvement in elementary school children's lunches and snacks from home 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... This release is available in Spanish . , ... defenses of U.S. varieties against Fusarium graminearum fungi ... According to Agricultural Research Service (ARS) plant molecular biologist Guihua ... is primarily based on the Chinese wheat variety Sumai 3 ...
... FL (April 1, 2010)-- University of Miami assistant professor ... collaborators have developed a fast, economical and easy method ... compound found in contaminated pet food and in tainted ... The laced dairy products were responsible for sickening thousands ...
... finch genome, a new resource has been made available ... by BioMed Central, the open access publisher, touches upon ... the series, a study published in BMC Neuroscience ... receptors and estrogen biosynthesis. Researchers writing in BMC ...
Cached Biology News:Diverse wheat tapped for antifungal genes 2Researchers develop new method to detect melamine in milk 2
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
... A simultaneous dual parameter assay ... poly caspase activity. Active caspases are ... peptide inhibitors, which are cell-permeable, non-cytotoxic ... caspases within the cells. At the ...
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
Biology Products: